http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 04 Jun 2026 10:10:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html <p align="justify">HENDERSON, Nev., June 04, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) is currently engaged in active discussions with several investors from Europe and the US who have demonstrated significant interest in NIKA; negotiations with two of these parties are in advanced stages.</p> <p align="justify">Because NIKA’s goal is not only to secure financing but also to gain a strong strategic partner, the negotiations take slightly more time; however, strong investor interest gives the Company the opportunity to secure the best possible investor.</p> <p align="justify">After the necessary funds have been secured, the pharmaceutical factory will be http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html Thu, 04 Jun 2026 10:10:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html <p align="justify">HENDERSON, Nev., June 04, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) is currently engaged in active discussions with several investors from Europe and the US who have demonstrated significant interest in NIKA; negotiations with two of these parties are in advanced stages.</p> <p align="justify">Because NIKA’s goal is not only to secure financing but also to gain a strong strategic partner, the negotiations take slightly more time; however, strong investor interest gives the Company the opportunity to secure the best possible investor.</p> <p align="justify">After the necessary funds have been secured, the pharmaceutical factory will be http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html Thu, 04 Jun 2026 10:10:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html <p align="justify">HENDERSON, Nev., June 04, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) is currently engaged in active discussions with several investors from Europe and the US who have demonstrated significant interest in NIKA; negotiations with two of these parties are in advanced stages.</p> <p align="justify">Because NIKA’s goal is not only to secure financing but also to gain a strong strategic partner, the negotiations take slightly more time; however, strong investor interest gives the Company the opportunity to secure the best possible investor.</p> <p align="justify">After the necessary funds have been secured, the pharmaceutical factory will be http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html Thu, 04 Jun 2026 10:10:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html <p align="justify">HENDERSON, Nev., June 04, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) is currently engaged in active discussions with several investors from Europe and the US who have demonstrated significant interest in NIKA; negotiations with two of these parties are in advanced stages.</p> <p align="justify">Because NIKA’s goal is not only to secure financing but also to gain a strong strategic partner, the negotiations take slightly more time; however, strong investor interest gives the Company the opportunity to secure the best possible investor.</p> <p align="justify">After the necessary funds have been secured, the pharmaceutical factory will be http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28OTCQB%3A+NIKA%29+June+2026+Update/26603826.html Thu, 04 Jun 2026 10:10:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Mar+31/26477144.html si-local-file:///var/storage/secattach/20260512/26477144.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Mar+31/26477144.html Tue, 12 May 2026 15:19:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Mar+31/26477144.html si-local-file:///var/storage/secattach/20260512/26477144.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Mar+31/26477144.html Tue, 12 May 2026 15:19:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Dec+31/26216937.html si-local-file:///var/storage/secattach/20260325/26216937.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Dec+31/26216937.html Wed, 25 Mar 2026 15:47:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Dec+31/26216937.html si-local-file:///var/storage/secattach/20260325/26216937.html http://www.streetinsider.com/SEC+Filings/Form++10-K+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Dec+31/26216937.html Wed, 25 Mar 2026 15:47:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html <p align="justify">HENDERSON, Nev., March 06, 2026 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) announces that it has signed a consultancy agreement with MD Global Partners LLC, a leading Manhattan-based investment bank. MD Global will provide NIKA with various services, which may include, but are not limited to assistance in capital raising efforts, growth initiatives, and conducting due diligence on potential transactions.</p> <p align="justify">“As we prepare for the next stages of our development, it is important that we have an advisor with proven track record and expertise”, stated Dimitar Savov, CEO of NIKA. “We expect significant growth http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Signed+a+Consultancy+Agreement+with+MD+Global+Partners+LLC/26123885.html Fri, 06 Mar 2026 11:58:00 -0400 A.50208219 NIKA O.05727401 O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html <p align="justify">HENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) appeared on <em>The Street Reports </em>podcast where CEO Dimitar Savov shared the progress the company has made thus far and outlined what is expected for 2026, which will be a crucial year for the company. You may listen to the podcast episode <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ndWtDqwJ4lETkhM1qT1P18VMK6CceX3BEUlKjMC8D1VBvqUqPI2QiWUl7I3AxIajd1fkztJLmieBVYdgLLvNAkxtggu2ymymoMilFt8q8BujUbTVL0Z3Wl081ZpUQ10zbZ33sxCyx6m2nwPWEWQX_xOAAuDrUaJq7cQsyXrbmVwwXAkxDcauD7IuwqR0iKOsByCHSAeaXOsuStspEZa2L5H2320kiz1CFe-uGOFBbQJcB6QiD_FG3m3ifvhUuvt9" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Additionally, NIKA’s partner, Nika Europe, is finalizing the technical project for the pharmaceutical factory and expects to begin construction soon. Given that the factory is a “building within a building”, the build up time will http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html Wed, 03 Dec 2025 11:58:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html <p align="justify">HENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) appeared on <em>The Street Reports </em>podcast where CEO Dimitar Savov shared the progress the company has made thus far and outlined what is expected for 2026, which will be a crucial year for the company. You may listen to the podcast episode <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ndWtDqwJ4lETkhM1qT1P18VMK6CceX3BEUlKjMC8D1VBvqUqPI2QiWUl7I3AxIajd1fkztJLmieBVYdgLLvNAkxtggu2ymymoMilFt8q8BujUbTVL0Z3Wl081ZpUQ10zbZ33sxCyx6m2nwPWEWQX_xOAAuDrUaJq7cQsyXrbmVwwXAkxDcauD7IuwqR0iKOsByCHSAeaXOsuStspEZa2L5H2320kiz1CFe-uGOFBbQJcB6QiD_FG3m3ifvhUuvt9" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Additionally, NIKA’s partner, Nika Europe, is finalizing the technical project for the pharmaceutical factory and expects to begin construction soon. Given that the factory is a “building within a building”, the build up time will http://www.streetinsider.com/Press+Releases/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html Wed, 03 Dec 2025 11:58:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html <p align="justify">HENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) appeared on <em>The Street Reports </em>podcast where CEO Dimitar Savov shared the progress the company has made thus far and outlined what is expected for 2026, which will be a crucial year for the company. You may listen to the podcast episode <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ndWtDqwJ4lETkhM1qT1P18VMK6CceX3BEUlKjMC8D1VBvqUqPI2QiWUl7I3AxIajd1fkztJLmieBVYdgLLvNAkxtggu2ymymoMilFt8q8BujUbTVL0Z3Wl081ZpUQ10zbZ33sxCyx6m2nwPWEWQX_xOAAuDrUaJq7cQsyXrbmVwwXAkxDcauD7IuwqR0iKOsByCHSAeaXOsuStspEZa2L5H2320kiz1CFe-uGOFBbQJcB6QiD_FG3m3ifvhUuvt9" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Additionally, NIKA’s partner, Nika Europe, is finalizing the technical project for the pharmaceutical factory and expects to begin construction soon. Given that the factory is a “building within a building”, the build up time will http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html Wed, 03 Dec 2025 11:58:00 -0400 NIKA O.61790030 http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html <p align="justify">HENDERSON, Nev., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Nika Pharmaceuticals, Inc. (OTCQB: <strong>NIKA</strong>) appeared on <em>The Street Reports </em>podcast where CEO Dimitar Savov shared the progress the company has made thus far and outlined what is expected for 2026, which will be a crucial year for the company. You may listen to the podcast episode <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ndWtDqwJ4lETkhM1qT1P18VMK6CceX3BEUlKjMC8D1VBvqUqPI2QiWUl7I3AxIajd1fkztJLmieBVYdgLLvNAkxtggu2ymymoMilFt8q8BujUbTVL0Z3Wl081ZpUQ10zbZ33sxCyx6m2nwPWEWQX_xOAAuDrUaJq7cQsyXrbmVwwXAkxDcauD7IuwqR0iKOsByCHSAeaXOsuStspEZa2L5H2320kiz1CFe-uGOFBbQJcB6QiD_FG3m3ifvhUuvt9" rel="nofollow" target="_blank">here</a>.</p> <p align="justify">Additionally, NIKA’s partner, Nika Europe, is finalizing the technical project for the pharmaceutical factory and expects to begin construction soon. Given that the factory is a “building within a building”, the build up time will http://www.streetinsider.com/Globe+Newswire/Nika+Pharmaceuticals%2C+Inc.+%28NIKA%29+Progress+Update/25694337.html Wed, 03 Dec 2025 11:58:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Sep+30/25577136.html si-local-file:///var/storage/secattach/20251107/25577136.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Sep+30/25577136.html Fri, 07 Nov 2025 12:15:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Sep+30/25577136.html si-local-file:///var/storage/secattach/20251107/25577136.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Sep+30/25577136.html Fri, 07 Nov 2025 12:15:00 -0400 NIKA O.61790030 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Jun+30/25203980.html si-local-file:///var/storage/secattach/20250814/25203980.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++NIKA+PHARMACEUTICALS%2C+++++For%3A+Jun+30/25203980.html Thu, 14 Aug 2025 12:56:00 -0400 NIKA http://www.streetinsider.com/Press+Releases/UPDATE+-+Nika+Pharmaceuticals%2C+Inc.+to+Present+at+the+Life+Sciences+Virtual+Investor+Forum+June+11th-12th/24930620.html <p>HENDERSON, Nev., June 12, 2025 (GLOBE NEWSWIRE) -- <strong>Nika Pharmaceuticals, Inc. </strong>(OTCQB:NIKA), based in Colorado, focused on cures for life-threatening diseases, today announced that Dimitar Savov, CEO, will present live at the Life Sciences Virtual Investor Frum hosted by <a target="_blank" href="http://VirtualInvestorConferences.com">VirtualInvestorConferences.com</a>, on June 11th, 2025</p> <p><strong>DATE</strong>: June 11th <br/><strong>TIME: 1:00 PM ET</strong><br/><strong>LINK:</strong> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4HVEuM1BeZcWG3ySh0pr8Lvy-znG2WXkl9dO1FpyzT5WDNzWD3R3druJlk6PAb-k5lyZbMnw7N6aFEpfA1yHcFSX6O_C7lMUYUf7LT9u-nur2y1dQiJNwRBKBgluq4gfeIcDys0IUN5K35IOBCOBOPxT87QF_dWp0pdQZyzvUtUgtBpZs6Ul7BNThs0kkoIbAWjAHzkhneqatntyzplqlgQ2tXQexrZC_6xwhX9L5cQZApaaZBbk0DcW8e1DlZ-0P_0EfQYGEjIbdfoaMd277SOaurYjI4hS7nYfsrW3co4=" rel="nofollow" target="_blank"><strong>REGISTER HERE</strong></a><br/>Available for 1x1 meetings: June 12th-17th between 09:00am ET and 11:30am ET</p> <p>This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event http://www.streetinsider.com/Press+Releases/UPDATE+-+Nika+Pharmaceuticals%2C+Inc.+to+Present+at+the+Life+Sciences+Virtual+Investor+Forum+June+11th-12th/24930620.html Thu, 12 Jun 2025 15:41:00 -0400 NIKA http://www.streetinsider.com/Globe+Newswire/UPDATE+-+Nika+Pharmaceuticals%2C+Inc.+to+Present+at+the+Life+Sciences+Virtual+Investor+Forum+June+11th-12th/24930620.html <p>HENDERSON, Nev., June 12, 2025 (GLOBE NEWSWIRE) -- <strong>Nika Pharmaceuticals, Inc. </strong>(OTCQB:NIKA), based in Colorado, focused on cures for life-threatening diseases, today announced that Dimitar Savov, CEO, will present live at the Life Sciences Virtual Investor Frum hosted by <a target="_blank" href="http://VirtualInvestorConferences.com">VirtualInvestorConferences.com</a>, on June 11th, 2025</p> <p><strong>DATE</strong>: June 11th <br/><strong>TIME: 1:00 PM ET</strong><br/><strong>LINK:</strong> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4HVEuM1BeZcWG3ySh0pr8Lvy-znG2WXkl9dO1FpyzT5WDNzWD3R3druJlk6PAb-k5lyZbMnw7N6aFEpfA1yHcFSX6O_C7lMUYUf7LT9u-nur2y1dQiJNwRBKBgluq4gfeIcDys0IUN5K35IOBCOBOPxT87QF_dWp0pdQZyzvUtUgtBpZs6Ul7BNThs0kkoIbAWjAHzkhneqatntyzplqlgQ2tXQexrZC_6xwhX9L5cQZApaaZBbk0DcW8e1DlZ-0P_0EfQYGEjIbdfoaMd277SOaurYjI4hS7nYfsrW3co4=" rel="nofollow" target="_blank"><strong>REGISTER HERE</strong></a><br/>Available for 1x1 meetings: June 12th-17th between 09:00am ET and 11:30am ET</p> <p>This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event http://www.streetinsider.com/Globe+Newswire/UPDATE+-+Nika+Pharmaceuticals%2C+Inc.+to+Present+at+the+Life+Sciences+Virtual+Investor+Forum+June+11th-12th/24930620.html Thu, 12 Jun 2025 15:41:00 -0400 NIKA